Last reviewed · How we verify
NCT03953859
Embryo DNA Repair Capacity Project
trial testing double strand break in Infertility in 6 participants. Completed in 9 December 2021.
30 April 2020
Quick facts
| Lead sponsor | Reproductive Medicine Associates of New Jersey |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 6 |
| Start date | 4 April 2019 |
| Primary completion | 30 April 2020 |
| Estimated completion | 9 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- double strand break
Conditions studied
- Infertility — all drugs for Infertility →
Sponsor
Reproductive Medicine Associates of New Jersey — full company profile →
Who can join
Adults 21 to 42, any sex, with Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The mail aim of the present study is to use molecular methods to analyze the ability of human preimplantation embryos to repair their DNA
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03953859
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Reproductive Medicine Associates of New Jersey trials
Trials by the same sponsor.
- NCT06074055 — PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer · NA · terminated
- NCT05853822 — FirmTech User Research Trial · completed
- NCT05397912 — Uterine Elastography: a Potential Predictor of Embryo Transfer Success · completed
- NCT04852029 — Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Ferti · NA · terminated
- NCT04693806 — The Effect of Embryo Culture Under a Continuous CO2 Setting Versus a Sequential CO2 Setting · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03953859 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Reproductive Medicine Associates of New Jersey
- Last refreshed: 14 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03953859.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing